Анна Сергеева

Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential

CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?

Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies

Building better monoclonal antibody-based therapeutics

A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice

Delivery technologies for cancer immunotherapy

Inflammation and tumor progression: signaling pathways and targeted intervention

Development of therapeutic antibodies for the treatment of diseases

Opportunities for Treg cell therapy for the treatment of human disease

Cancer‐related circulating and tumor‐associated neutrophils – subtypes, sources and function

T-Cell Receptor-Like Antibodies: Targeting the Intracellular Proteome Therapeutic Potential and Clinical Applications

Acute myeloid leukaemia

A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells

Interaction between Tumor Cell Surface Receptor RAGE and Proteinase 3 Mediates Prostate Cancer Metastasis to Bone

An anti–PR1/HLA-A2 T-cell receptor–like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells